Anthropic CEO Dario Amodei will meet one-on-one with former President Donald Trump for dinner at the White House, in a notable encounter between two figures with contrasting perspectives on artificial intelligence development and regulation.
- First private meeting between Amodei and Trump.
- Amodei advocates for cautious AI development.
- Trump dismisses AI concerns as partisan misinformation.
What happened
Anthropic CEO Dario Amodei is scheduled to have dinner with former President Donald Trump at the White House. This will be their first direct, private meeting. The news was initially reported by Axios and later confirmed by TechCrunch.
The dinner comes after Amodei was prominently featured in public discourse over AI safety, including being parodied on Saturday Night Live, and amid tensions between Anthropic and members of the Trump administration concerning AI risks.
Why it matters
This meeting is significant because the two figures represent opposing views on artificial intelligence technologies. Amodei has publicly advocated slowing or more prudently managing AI's development to reduce risks, while Trump has framed AI backlash as a politically motivated issue and prefers to rebrand the technology as “super intelligence.”
Anthropic’s friction with the Trump-era Pentagon, which labeled the company a supply-chain risk due to its efforts to implement ethical guardrails, underscores ongoing government challenges regarding emerging technologies. Other officials, however, have taken a more favorable stance toward the company.
What to watch next
Observers will be looking to see if this dinner yields common ground or shifts in policy or public messaging from either side concerning AI regulation and safety. The meeting could influence growing national and global conversations about how to balance innovation with risk management in AI.
Further developments may also arise from how Anthropic continues to engage with U.S. government entities following its legal challenge against the Pentagon’s designation as a supply-chain risk, which could have broader implications for AI companies navigating regulatory scrutiny.